ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus-Reference-Cited by-同舟云学术

ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus

Published:2018-04-24 Issue:6 Volume:218 Page:901-910
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Yang Bing¹,Schaefer Alison²,Wang Ying-Ying³,McCallen Justin²,Lee Phoebe²,Newby Jay M⁴,Arora Harendra⁵,Kumar Priya A⁵,Zeitlin Larry⁶,Whaley Kevin J⁶,McKinley Scott A⁷,Fischer William A⁸,Harit Dimple¹,Lai Samuel K¹²⁹^ORCID

Affiliation:

1. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, Chapel Hill, North Carolina

2. University of North Carolina/North Carolina State University Joint Department of Biomedical Engineering, Chapel Hill, North Carolina

3. Department of Biophysics, Johns Hopkins University, Baltimore, Maryland

4. Department of Mathematics and Applied Physical Sciences, Chapel Hill, North Carolina

5. Department of Anesthesiology, School of Medicine, Chapel Hill, North Carolina

6. Mapp Biopharmaceutical, Inc, San Diego, California

7. Mathematics Department, Tulane University, New Orleans, Louisiana

8. Division of Pulmonary and Critical Care Medicine, School of Medicine, Chapel Hill, North Carolina

9. Department of Microbiology & Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Funder

North Carolina Translational & Clinical Sciences Institute

National Institute of Allergy and Infectious Diseases

David and Lucile Packard Foundation

Eshelman Institute for Innovation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/6/901/25469487/jiy230.pdf

Reference50 articles.

1. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses;Martines;J Pathol,2015

2. Filovirus tropism: cellular molecules for viral entry;Takada;Front Microbiol,2012

3. A randomized, controlled trial of ZMapp for Ebola virus infection;Davey;N Engl J Med,2016

4. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days;Diallo;Clin Infect Dis,2016

5. Transmission of Ebola viruses: what we know and what we do not know;Osterholm;MBio,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus;Emerging Microbes & Infections;2024-09-04

2. ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucus;Emerging Microbes & Infections;2024-05-16

3. Engineering a “muco‐trapping” ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19;Bioengineering & Translational Medicine;2024-02-07

4. Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections;Advanced Science;2024-01-15

5. Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals;Acta Biomaterialia;2023-10